Publication | Open Access
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
7.1K
Citations
20
References
2005
Year
Patients with glioblastoma containing a methylated MGMT promoter benefited from temozolomide, whereas those who did not have a methylated MGMT promoter did not have such a benefit.
| Year | Citations | |
|---|---|---|
Page 1
Page 1